55 results
8-K
EX-99.1
REVB
Revelation Biosciences Inc
10 May 24
Results of Operations and Financial Condition
4:57pm
. The increase in cash and cash equivalents was primarily due to net cash received from financing activities, offset primarily by cash used for operating
8-K
EX-99.1
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
cash received from financing activities, offset primarily by cash used for operating activities. Based on current operating plans and projections
424B3
REVB
Revelation Biosciences Inc
2 Feb 24
Prospectus supplement
4:06pm
due to decreases of $3.1 million in clinical study expenses related to REVTx-99a and $0.6 million in personnel expenses, offset by increases of $1.7 … in financial advisory fees, legal fees and professional consulting service fees, offset by a decrease of $0.2 million in other expenses as a result
8-K
EX-99.1
zyq1jq952lyi6gluifo
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
EX-99.1
ir6s0qz
11 Aug 23
Results of Operations and Financial Condition
4:30pm
8-K
EX-99.1
uchvysxj
22 May 23
Results of Operations and Financial Condition
1:22pm
8-K
EX-99.1
9iz0q4
3 Apr 23
Results of Operations and Financial Condition
4:33pm
8-K
EX-99.1
fjnyvzmnpwy1moyfl
10 Nov 22
Results of Operations and Financial Condition
5:00pm